发明授权
US08163499B2 Drug selection for breast cancer therapy using antibody-based arrays
有权
使用基于抗体的阵列进行乳腺癌治疗的药物选择
- 专利标题： Drug selection for breast cancer therapy using antibody-based arrays
- 专利标题（中）： 使用基于抗体的阵列进行乳腺癌治疗的药物选择
-
申请号： US12511017申请日： 2009-07-28
-
公开(公告)号： US08163499B2公开(公告)日： 2012-04-24
- 发明人: Sharat Singh , Jeanne Harvey , Phillip Kim , Xinjun Liu , Limin Liu , Robert Barham , Bruce Neri
- 申请人： Sharat Singh , Jeanne Harvey , Phillip Kim , Xinjun Liu , Limin Liu , Robert Barham , Bruce Neri
- 申请人地址： US CA San Diego
- 专利权人： Prometheus Laboratories Inc.
- 当前专利权人： Prometheus Laboratories Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Kilpatrick Townsend & Stockton LLP
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; G01N33/58 ; G01N33/68 ; G01N33/545 ; G01N33/574
摘要：
The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
公开/授权文献
信息查询
IPC分类:
